Literature DB >> 10889403

Molecular characterization of canine parvovirus in Brazil by polymerase chain reaction assay.

C A Pereira1, T A Monezi, D U Mehnert, M D'Angelo, E L Durigon.   

Abstract

Canine parvovirus (CPV) was first isolated in 1978 in the USA. Analysis of CPV isolates by monoclonal antibodies and restriction enzymes have shown that after the first emergence of CPV (CPV-2) it evolved to give rise to new antigenic types, which were designated CPV type 2a and type 2b. These new types have replaced the original CPV type 2, although the proportions of each of the new antigenic types vary in different countries. In Brazil, CPV-like infections were first observed in 1979, however, there has been no information concerning the antigenic types of CPV prevailing in South America. In this study, we designed a PCR assay to type canine parvovirus strains in fecal samples collected from symptomatic dogs during 1980 through 1986 and 1990 through 1995. Our data showed that the CPV epizootic in Brazil followed the same pattern observed in the USA of emergence of CPV-2 followed by replacement by the variants CPV-2a and 2b. The predominant strain found during 1980 was CPV-2a, which was substantially replaced by CPV-2b from 1990 to 1995.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889403     DOI: 10.1016/s0378-1135(00)00214-5

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  43 in total

1.  Misleading results of the MboII-based identification of type 2a canine parvovirus strains from Hungary reacting as type 2c strains.

Authors:  Zoltán Demeter; Elena Alina Palade; Tibor Soós; Attila Farsang; Csaba Jakab; Miklós Rusvai
Journal:  Virus Genes       Date:  2010-08       Impact factor: 2.332

2.  Immunogenicity of an intranasally administered modified live canine parvovirus type 2b vaccine in pups with maternally derived antibodies.

Authors:  Vito Martella; Alessandra Cavalli; Nicola Decaro; Gabriella Elia; Costantina Desario; Marco Campolo; Giancarlo Bozzo; Elvira Tarsitano; Canio Buonavoglia
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

3.  Evolution of CPV-2 and implication for antigenic/genetic characterization.

Authors:  Vito Martella; Nicola Decaro; Canio Buonavoglia
Journal:  Virus Genes       Date:  2006-08       Impact factor: 2.332

4.  Sequence analysis of VP2 gene of canine parvovirus isolates in Thailand.

Authors:  Siriwadee Phromnoi; Kaitkanoke Sirinarumitr; Theerapol Sirinarumitr
Journal:  Virus Genes       Date:  2010-03-30       Impact factor: 2.332

5.  Genomic typing of canine parvovirus circulating in the State of Rio de Janeiro, Brazil from 1995 to 2001 using polymerase chain reaction assay.

Authors:  A P Costa; J P G Leite; N V Labarthe; R C N Cubel Garcia
Journal:  Vet Res Commun       Date:  2005-11       Impact factor: 2.459

6.  Evidence of feline panleukopenia infection in cats in India.

Authors:  Manoharan Parthiban; Komandur Seshadri Aarthi; Mani Balagangatharathilagar; Kathaperumal Kumanan
Journal:  Virusdisease       Date:  2014-11-01

7.  Isolation and Typing of Canine Parvovirus in CRFK Cell Line in Puducherry, South India.

Authors:  S Parthiban; Hirak Kumar Mukhopadhyay; D Panneer; P X Antony; R M Pillai
Journal:  Indian J Microbiol       Date:  2011-01-21       Impact factor: 2.461

8.  A novel one-step amplification refractory mutation system PCR (ARMS-PCR) for differentiation of canine parvovirus-2 variants.

Authors:  Anusha Dema; Vishweshwar Kumar Ganji; Narasimha Reddy Yella; Kalyani Putty
Journal:  Virus Genes       Date:  2021-07-13       Impact factor: 2.332

9.  Characterization of the partial VP2 gene region of canine parvoviruses in domestic cats from Turkey.

Authors:  Dilek Muz; T Ciğdem Oğuzoğlu; M Ozkan Timurkan; Hümay Akın
Journal:  Virus Genes       Date:  2011-12-30       Impact factor: 2.332

10.  A canine parvovirus mutant is spreading in Italy.

Authors:  Vito Martella; Alessandra Cavalli; Annamaria Pratelli; Giancarlo Bozzo; Michele Camero; Domenico Buonavoglia; Donato Narcisi; Maria Tempesta; Canio Buonavoglia
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.